Specific clotting condition reported after COVID-19 vaccination
Some rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.
- AstraZeneca ChAdOx1-S COVID-19 vaccineUpdated safety advisory - rare and unusual blood clotting syndrome (thrombosis with thrombocytopenia)
- COVID-19 vaccine weekly safety report - 07-04-2021Information about the TGA's safety monitoring of COVID-19 vaccines
- COVID-19 vaccine weekly safety report - 14-04-2021Information about the TGA's safety monitoring of COVID-19 vaccines